Raymond Yau, MD
Interventional Cardiology · Albuquerque, NMNPI 1497932503
Payments from drug & device makers
Across 1,045 payments — averaging $205.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$93K
- Abbott$65K
- Livanova USA, Inc.$41K
- Boston Scientific$5K
- Asahi Intecc USA, Inc.$3K
- Philips North America LLC$2K
- plus $5K from 29 others
Across 6 payments — averaging $67.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abiomed$408
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 349 | $93,200 |
| Abbott | 181 | $65,277 |
| Livanova USA, Inc. | 61 | $40,773 |
| Boston Scientific | 138 | $4,995 |
| Asahi Intecc USA, Inc. | 34 | $3,320 |
| Philips North America LLC | 52 | $1,914 |
| Shockwave Medical, Inc | 53 | $965 |
| Cardiovascular Systems Inc. | 22 | $628 |
| Medtronic(2 entities) | 19 | $584 |
| Amgen | 34 | $521 |
| Johnson & Johnson | 16 | $308 |
| Novartis | 12 | $274 |
| AstraZeneca | 17 | $271 |
| E.r. Squibb & Sons, L.L.C. | 14 | $252 |
| Cvrx, Inc. | 3 | $247 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 13 | $209 |
| Chiesi USA, Inc. | 2 | $139 |
| AbbVie | 1 | $135 |
| Portola Pharmaceuticals, LLC | 1 | $132 |
| Pfizer | 4 | $74 |
| Edwards Lifesciences | 2 | $33 |
| Inspire Medical Systems, Inc. | 1 | $31 |
| Boehringer Ingelheim | 2 | $29 |
| Merck | 2 | $28 |
| EKOS Corporation | 1 | $26 |
| Biosense Webster, Inc. | 2 | $24 |
| Cordis US CORP. | 1 | $21 |
| W. L. Gore & Associates, Inc. | 1 | $21 |
| Teleflex LLC | 1 | $21 |
| Terumo Medical Corporation | 1 | $20 |
| Baxter Healthcare | 1 | $19 |
| Ancora Heart, Inc. | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
| Bayer | 1 | $12 |
| Amarin Pharma, Inc. | 1 | $11 |
How this compares
$214,541 in reported general payments places this provider in the 90th percentile of 25 interventional cardiology providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Albuquerque
- James BlankenshipAlbuquerque$782K
- Mark BieniarzAlbuquerque$299K
- Robert FedericiAlbuquerque$77K
- Geoffrey KunzAlbuquerque$35K
- Sharif HalimAlbuquerque$34K
- Charles KimAlbuquerque$20K
- Harvey WhiteAlbuquerque$3K
- Guilherme MarinAlbuquerque$3K
- John BattyAlbuquerque$82
- Abdul KhanLas Cruces$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.